Very interesting, thanks sstyles. I do think a new once-daily formulation may be ready to launch before the oft-mentioned fixed dose combination IPE+statin combo pill, and may be the key to life-cycle management as applied to recovering from a tragic DUsaster of the VHTG patents loss. I have to believe Amarin has been working towards this for quite a while (Mochida collaboration and MND-2119 patent date to 2019), and we could see something on this front sooner rather than later.
News 
Market Data 
Discover 
